Form 144 ALECTOR For: 26 February
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alector Inc (ALEC)
Alector Inc stock price live, this page displays NASDAQ ALEC stock exchange data. View the ALEC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Alector Inc real time stock price chart below.
What Is the Alector Inc Stock Price Today?
The Alector Inc stock price today is 2.45.
What Is the Stock Symbol for Alector Inc?
The stock symbol for Alector Inc is "ALEC."
What Stock Exchange Does Alector Inc Trade On?
Alector Inc is listed and trades on the NASDAQ stock exchange.
Is Alector Inc a Good Stock to Buy?
Determining whether Alector Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALEC quote. (ISIN: US0144421072)
What Is the Alector Inc Stock Price Today?
The Alector Inc stock price today is 2.45.
What Is the Stock Symbol for Alector Inc?
The stock symbol for Alector Inc is "ALEC."
What Stock Exchange Does Alector Inc Trade On?
Alector Inc is listed and trades on the NASDAQ stock exchange.
Is Alector Inc a Good Stock to Buy?
Determining whether Alector Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALEC quote. (ISIN: US0144421072)
2.45
-0.11(-4.30%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.34
2.53
52 wk Range
0.87
3.40
ALEC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.342.53
52 wk Range
0.873.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALEC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
2.10
Downside
-14.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Alector CEO Rosenthal sells $116k in shares
- Investing.com
- Form 144 ALECTOR For: 26 February
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Alector Inc Company Profile
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer’s disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson’s disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer’s disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson’s disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.
Alector Inc Earnings Call Summary for Q2/2025
- Alector beats Q2 2025 forecasts: EPS of -$0.30 vs -$0.47 expected, revenue of $7.9M vs $4.7M anticipated
- Strong cash position of $307.3M expected to last into 2027; stock up 2.1% after hours to $1.46
- Phase III trial of Latozinimab for FTD and Phase II for Alzheimer's progressing; results expected mid-Q4 2025
- 2025 guidance: Collaboration revenue $13-18M, R&D expenses $130-140M; focus on neurodegenerative therapies
- Challenges include regulatory hurdles, market competition, and maintaining financial sustainability
Last Updated: 2025/08/08, 12:36
Read Full TranscriptCompare ALEC to Peers and Sector
Metrics to compare | ALEC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALECPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −1.5x | −0.6x | |
PEG Ratio | 0.15 | 0.11 | 0.00 | |
Price/Book | 8.7x | 3.0x | 2.6x | |
Price / LTM Sales | 12.7x | 156.8x | 3.3x | |
Upside (Analyst Target) | −51.2% | 150.1% | 44.5% | |
Fair Value Upside | Unlock | 5.3% | 5.2% | Unlock |
Analyst Ratings
1 Buy
5 Hold
2 Sell
Ratings:
8 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 2.10
(-14.29% Downside)
Earnings
Latest Release
Feb 26, 2026
EPS / Forecast
-0.34 / -0.39
Revenue / Forecast
6.20M / 2.38M
FAQ
What Is the Alector (ALEC) Stock Price Today?
The Alector stock price today is 2,45 USD.
What Stock Exchange Does Alector Trade On?
Alector is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Alector?
The stock symbol for Alector is "ALEC."
What Is the Alector Market Cap?
As of today, Alector market cap is 266,33M USD.
What Is Alector's Earnings Per Share (TTM)?
The Alector EPS (TTM) is -1,39.
When Is the Next Alector Earnings Date?
Alector will release its next earnings report on Apr 30, 2026.
From a Technical Analysis Perspective, Is ALEC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Alector Stock Split?
Alector has split 0 times.
How Many Employees Does Alector Have?
Alector has 156 employees.
What is the current trading status of Alector (ALEC)?
As of Feb 27, 2026, Alector (ALEC) is trading at a price of 2,45 USD, with a previous close of 2,56 USD. The stock has fluctuated within a day range of 2,34 USD to 2,53 USD, while its 52-week range spans from 0,87 USD to 3,40 USD.
What Is Alector (ALEC) Price Target According to Analysts?
The average 12-month price target for Alector is 2,10 USD, with a high estimate of 5 USD and a low estimate of 0.9 USD. 1 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an -14,29% Downside potential.
What Is the ALEC Premarket Price?
ALEC's last pre-market stock price is 2,55 USD. The pre-market share volume is 1 000,00, and the stock has decreased by -0,01, or -0,39%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.